NCT07571993 Rheumatoid Arthritis Remission Screening and Prospective Surveillance Status RECRUITING Phase N/A
NCT07566351 Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis Status RECRUITING Phase PHASE2
NCT07558850 Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases Status RECRUITING Phase NA
NCT07554820 Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL Status RECRUITING Phase PHASE4
NCT07497282 Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis Status NOT_YET_RECRUITING Phase PHASE2
NCT07491016 Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis Status RECRUITING Phase N/A
NCT07489326 The SetPoint System Safety & Performance Post-Approval Study Status NOT_YET_RECRUITING Phase N/A
NCT07452445 Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis Status NOT_YET_RECRUITING Phase PHASE4
NCT07433335 A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis Status RECRUITING Phase PHASE1
NCT07423533 Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD Status RECRUITING Phase PHASE2
NCT07363980 Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study Status ENROLLING_BY_INVITATION Phase N/A
NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) Status RECRUITING Phase PHASE1
NCT07360496 Core Endurance, Finger Grip Strength, Fatigue, and Hand Function in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT07357649 Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis Status NOT_YET_RECRUITING Phase PHASE4
NCT07349420 EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT07335952 Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial. Status COMPLETED Phase PHASE2
NCT07320846 The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis Status RECRUITING Phase NA